Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Detax
DETAX is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical applications in the dental and audio sectors. Based in Germany, it supplies its products via original equipment manufacturers (OEMs) to dental practices, dental laboratories, audiologists,
Private Equity
Novicare
Novicare provides specialist medical and paramedical (tele)care for elderly patients and people with disabilities in the Netherlands. It treats patients with complex and chronic conditions in both care homes and domiciliary settings. The company’s digitally enabled team comprises multidisciplinary experts
Private Equity
Ace Pharmaceuticals
Ace Pharmaceuticals is a leading independent specialty pharma company supplying medical need products to satisfy the unmet demand of patients with rare diseases or specific indications. Through its state-of-the-art facility in Zeewolde, the Netherlands, Ace conducts the development, production, and
